Vitality Re IX

Share

Aetna’s medical benefit ratio drops further below Vitality Re ILS trigger in Q2

For the second-quarter of 2020, the medical benefit claims ratio reported by CVS-owned health insurer Aetna dropped even further below levels where its Vitality Re series of health insurance-linked securities (ILS) transactions could be triggered. This is despite the impacts of the Covid-19 coronavirus pandemic, which might have been thought a read the full article →

Aetna’s claim ratio well-below Vitality Re ILS trigger in Q1 despite Covid-19

Despite the impacts of the Covid-19 coronavirus pandemic, the medical benefit claims ratio reported by insurer Aetna for the first-quarter of 2020 has remained well-below the levels where its Vitality Re series of health insurance-linked securities (ILS) transactions could be triggered, we can report. As we'd explained previously, the Vitality Re read the full article →

Vitality Re health ILS all discounted in secondary market on Covid-19

The secondary market prices for the Vitality Re series of health insurance-linked securities (ILS) transactions have all been discounted on the potential for the ongoing Covid-19 coronavirus pandemic to drive an elevated level of medical benefit claims through to insurer and sponsor Aetna. As we explained more than a week ago, read the full article →

Vitality Re health ILS at risk from coronavirus morbidity stress: S&P

The Vitality Re series of health insurance-linked securities (ILS) transactions, which provide reinsurance protection to health insurer Aetna, are exposed to potential triggering by the coronavirus pandemic should it result in "severe morbidity stress", rating agency S&P has said. The Vitality Re series of health ILS transactions are a way for read the full article →